(Q44061261)

29 November 2017

Steroid-hormone receptors and survival after first relapse in breast cancer (English)

1 reference

29 November 2017

1

1 reference

29 November 2017

D M Barnes

2

1 reference

29 November 2017

R N Harland

3

1 reference

29 November 2017

J Redford

4

1 reference

29 November 2017

V H Bramwell

5

1 reference

29 November 2017

M J Wilkinson

6

1 reference

29 November 2017

R Swindell

7

1 reference

29 November 2017

D Crowther

8

1 reference

29 November 2017

R A Sellwood

9

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 March 1984

1 reference

29 November 2017

1 reference

29 November 2017

1

1 reference

29 November 2017

588-591

1 reference

29 November 2017

8377

1 reference

Oestrogen receptors and prognosis in early breast cancer

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Estrogen receptor level and other factors in early recurrence of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Estrogen receptor: A prognostic factor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Influence and significance of certain prognostic factors on survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Relationship between primary breast tumor receptor status and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Estrogen receptor protein in breast cancer as a predictor of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Prognostic value of estrogen receptors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Prognostic significance of the steroid receptor content in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Oestrogen receptors and survival in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Assessment of response to therapy in advanced breast cancer (an amendment)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990995-4

7 January 2021

10.1016/S0140-6736(84)90995-4

Identifiers

DOI

1 reference

29 November 2017

1 reference